Acumen Hypotension Prediction Index (HPI) Feature Software vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on real-time predictive monitoring of hypotension to enable proactive hemodynamic management in critical care settings. In contrast, Tool B automates the interpretation and reporting of echocardiograms for diagnostic purposes, including disease detection. While both utilize AI in cardiology, they address distinct clinical problems and workflows, making them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Acumen Hypotension Prediction Index (HPI) Feature Software is designed for predictive monitoring to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. Us2.v2 automates echocardiogram interpretation, delivering a complete structured echo report with measurements, disease detection, and clinical findings.
Acumen HPI is intended for anesthesiology, critical care, and emergency medicine, focusing on patients requiring hemodynamic monitoring. Us2.v2 is specifically designed for cardiology, assisting cardiologists, sonographers, and other licensed healthcare professionals in clinical decision-making related to echocardiography.
Acumen HPI is integrated into Edwards Lifesciences HemoSphere advanced monitoring platform. Us2.v2 offers flexible deployment options, including cloud and on-premise, and integrates seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR.
Acumen HPI uses machine learning algorithms to analyze blood pressure waveforms from both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. Us2.v2 processes transthoracic cardiac ultrasound images to automate the analysis and measurement of various cardiac parameters.
Acumen HPI predicts hypotension up to 15 minutes before an event, with an adjustable Mean Arterial Pressure (MAP) target for its definition. Us2.v2 automates the detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, among other cardiac conditions.
Acumen HPI has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension, aiding proactive hemodynamic management. Us2.v2 reduces echocardiogram reporting time by up to 70% and increases daily scan throughput, while also aiming to eliminate intra-user variability.